Exelixis, Inc. v. Handa Pharmaceuticals, Inc.
1:26-cv-00813
Overview
Parties
Defendant
Handa Pharmaceuticals, Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 19 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 9,174,947 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,178,532 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,476,298 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,067,436 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,579,473 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2011007723 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,497,284 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012018452 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2014015537 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2014015539 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2015037613 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016018572 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,124,482 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 50,618,103 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 53,537,704 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9174947
c-Met modulators and methods of use
|
Filed: 2006-10-26
Issued: 2015-11-03
|
Active (3.3 yrs remaining)
+1225d PTA
Expires: 2030-03-04
|
|
|
US9365516
Process for preparing quinoline derivatives
|
Filed: 2012-10-22
Issued: 2016-06-14
|
Active (5.9 yrs remaining)
Expires: 2032-10-22
|
|
|
US9969692
Process for preparing quinoline derivatives
|
Filed: 2016-04-20
Issued: 2018-05-15
|
Active (9.4 yrs remaining)
Expires: 2036-04-20
|
|
|
US10123999
Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
|
Filed: 2016-11-10
Issued: 2018-11-13
|
Active (10.0 yrs remaining)
Expires: 2036-11-10
|
|
|
US10736886
Methods of using c-Met modulators
|
Filed: 2019-01-18
Issued: 2020-08-11
|
Active (12.2 yrs remaining)
Expires: 2039-01-18
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+1225 days) / Cellect Scrutiny β Over 1225 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
0
Granted
0
Denied
0
Pending / Review
2
Motions by Category
Key Dispositive Motions & Rulings